Other gonococcal infection of lower genitourinary tract
ICD-10 A54.09 is a billable code used to indicate a diagnosis of other gonococcal infection of lower genitourinary tract.
A54.09 refers to other gonococcal infections affecting the lower genitourinary tract, which includes conditions such as gonococcal urethritis and cervicitis. These infections are caused by the bacterium Neisseria gonorrhoeae, a common sexually transmitted infection (STI). Symptoms may include dysuria, increased urinary frequency, purulent discharge, and pelvic pain. In women, it can lead to cervicitis, which may present with abnormal vaginal discharge and bleeding. If left untreated, gonococcal infections can result in serious complications, including pelvic inflammatory disease (PID) in women and epididymitis in men. The diagnosis is typically confirmed through laboratory testing, including nucleic acid amplification tests (NAATs) or culture. Treatment usually involves antibiotics, with dual therapy recommended to combat potential resistance. Contact tracing is crucial to prevent reinfection and further transmission, emphasizing the importance of notifying sexual partners. Public health guidelines recommend routine screening for at-risk populations, including sexually active adolescents and young adults.
Detailed patient history, laboratory results, treatment plans, and follow-up notes.
Management of patients with recurrent gonococcal infections or those with co-infections.
Consideration of antibiotic resistance patterns and patient adherence to treatment.
Clinical findings, diagnostic imaging if applicable, and treatment protocols.
Evaluation of male patients presenting with urethritis or epididymitis.
Differentiating between gonococcal and non-gonococcal urethritis.
Used for confirming a diagnosis of gonococcal infection.
Document the reason for testing and patient consent.
Infectious disease specialists may require additional details on patient history.
Common symptoms include dysuria, purulent discharge, and pelvic pain. Women may also experience abnormal vaginal bleeding.
Diagnosis is typically made through laboratory testing, including NAATs or culture, alongside clinical evaluation.
The CDC recommends dual therapy with ceftriaxone and azithromycin to effectively treat gonococcal infections.
